Cisbio, 62CGLPEG) according to the manufacturers protocol, and protein was quantified using a BCA Protein Quantification Kit (Invitrogen, A55865)
It is often used to manage conditions characterized by chronic inflammation, including inflammatory bowel disease (IBD), skin conditions like psoriasis, and systemic inflammatory responses
Future studies with extended diet exposure and/or the use of rodent disease models are necessary to further explore the potential benefits of GE2 treatment
In comparison with naturally occurring receptor ligands, retatrutide has lower potency at the human glucagon and GLP-1 receptors, at approximately 0.3- and 0.4-fold, respectively, while showing markedly greater potency at the human GIP receptor, at about 8.9-fold
Specifics and limitations